Skip to content

Non-invasive biomarkers of UV-radiation

Non-invasive biomarkers of UV-radiation - UV-radiation biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47995
Enrollment
12
Registered
2019-03-14
Start date
2019-03-25
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin cancer

Interventions

Broad-band UV exposure of the back skin of the volunteers at sub-erythemal dose of 20-30 mJ/cm2, 3 times weekly during 3 weeks. Before each UV-irradiation samples urine and stratum corneum will be c

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Male individuals between 18 and 65 years. * Fitzpatrick skin types II or III. * Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator. * Individuals who have read, understood and signed an informed consent document relat-ing to the specific study to which they are subscribing. * Individuals with no known abnormal response to sunlight (e.g. polymorphic eruption).

Exclusion criteria

Exclusion criteria: * Individuals taking medication which in the opinion of the investigator would mask or in-terfere with the results. * Individuals with chronic skin allergies. * Individuals with abnormal reaction to the sun. * Subjects who used sun beds in the previous 30 days.

Design outcomes

Primary

MeasureTime frame
The levels of urocanic acid isomers, MMP, cytokines and DNA-photoproducts measured in the stratum corneum and/or urine at different time points during a 3-weeks study

Secondary

MeasureTime frame
The levels of urocanic acid isomers, MMP, cytokines and DNA-photoproducts at different stratum corneum depths (i.e. 1st to 12th collected tape from the same skin site)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)